JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Canning, B. J.
Right arrow Articles by Undem, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Canning, B. J.
Right arrow Articles by Undem, B. J.

Vol. 284, Issue 1, 370-377, 1998

Pharmacological Analysis of the Tachykinin Receptors that Mediate Activation of Nonadrenergic, Noncholinergic Relaxant Nerves that Innervate Guinea Pig Trachealis1

Brendan J. Canning, Axel Fischer and Bradley J. Undem

The Johns Hopkins Asthma and Allergy Center (B.J.C., B.J.U.), Baltimore, Maryland and Justus-Liebig University, Institute for Anatomy and Cell Biology (A.F.), Giessen, Germany


    Abstract
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Previous studies indicated that antidromic stimulation of capsaicin-sensitive vagal afferent fibers activated, via peripheral release of tachykinins, nonadrenergic, noncholinergic parasympathetic ganglion neurons that mediate relaxations of guinea pig trachealis. On the basis of the effects of selective agonists and inhibition with a nonselective receptor antagonist (SR 48968), we speculated that tachykinin-mediated activation of neurokinin3 (NK3) receptors might be involved. Using the recently developed NK3-selective receptor antagonist SR 142801, we further assessed the role of NK3 receptors in these relaxant responses. Relaxations of the guinea pig trachea elicited by antidromic stimulation of capsaicin-sensitive vagal afferent nerves were markedly inhibited by 0.3 µM SR 142801 and were abolished by a combination of SR 142801 and either of the NK1-selective receptor antagonists SR 140333 and CP 99994 (0.3 µM each). The NK3 receptor antagonist had similar effects on the relaxant responses elicited by capsaicin and substance P, but it had no effect on relaxations of the trachealis elicited by electrical field stimulation of the postganglionic nerves that innervate the trachealis or by stimulation of the preganglionic parasympathetic vagal nerves that innervate the trachea. These results and the observation that the ganglion neurons that mediate these responses are densely innervated by substance P-containing nerve fibers lead us conclude that stimulation of capsaicin-sensitive visceral afferent fibers activates, upon peripheral release of tachykinins, nonadrenergic, noncholinergic inhibitory neurons innervating guinea pig trachealis via activation of both NK3 and NK1 receptors.


    Introduction
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Studies carried out in the heart (Thorén, 1979), airways (Coleridge et al., 1989), GI tract (Szurzewski and King, 1989), gallbladder (Mawe, 1995) and bladder (de Groat et al., 1993; de Groat and Booth, 1993) indicate that capsaicin-sensitive afferent fibers regulate the activity of autonomic nerves that innervate the viscera. In many instances, activation of the capsaicin-sensitive afferent fibers elicits changes in end organ function only when the preganglionic nerves that innervate the relevant autonomic ganglia are intact and functional (Thorén, 1979; Szurzewski and King, 1989; Coleridge et al., 1989; de Groat et al., 1993). These observations indicate that capsaicin-sensitive afferent nerves elicit changes in autonomic nerve activity via centrally mediated autonomic reflexes.

It is equally apparent, however, that another site of action of these afferent nerves may be in the periphery, within autonomic ganglia (Kreulen and Peters, 1986; Myers and Undem, 1993; de Groat and Booth, 1993; Myers et al., 1996). Anatomical studies have demonstrated the presence of axon collaterals from these visceral afferent fibers in autonomic ganglia (Szurzewski and King, 1989; de Groat and Booth, 1993; Myers et al., 1996). Furthermore, studies carried out in isolated ganglia have demonstrated effects of these afferent nerves on the electrophysiological properties of the autonomic ganglion neurons after selective stimulation of their sensory/afferent nerve terminals (Szurzewski and King, 1989; de Groat and Booth, 1993; Myers et al., 1996). In addition to centrally mediated reflexes, then, capsaicin-sensitive afferent nerves may modulate autonomic nerve activity by modulating neuronal excitability through peripheral reflexes.

Tachykinins are transmitters that are frequently associated with the nerve terminals of visceral afferent nerves (Canning, 1997). Acting on NK1, NK2 and NK3 receptors, which are selectively (but not specifically) activated by substance P, NKA and NKB, respectively, the tachykinins are thought to mediate many of the central and peripheral actions of afferent nerves (Canning, 1997).

Capsaicin-sensitive vagal afferent fibers that innervate the airways contain NKA and substance P (Kummer et al., 1992). In several species, including humans, tachykinin-containing nerve endings innervate many structures within the airway wall, including airway parasympathetic ganglia (Kummer et al., 1992; Fischer and Hoffman, 1996; Dey et al., 1996; Myers et al., 1996). Because activation of these afferent nerves can modulate parasympathetic nerve activity both in vivo (Martling et al., 1984) and in vitro (Myers and Undem, 1991, 1993; Watson et al., 1993; Myers et al., 1996) and because their effects are mimicked by exogenously administered tachykinins and blocked by tachykinin receptor antagonists, it seems likely that airway parasympathetic nerve activity is modulated by peripherally released tachykinins.

In a previous study of the parasympathetic relaxant innervation of guinea pig airways, we presented evidence that collaterals from capsaicin-sensitive vagal afferent fibers can activate the NANC parasympathetic ganglion neurons that innervate the trachealis, thus eliciting, via noncholinergic synaptic neurotransmission, NANC relaxations of the trachealis (Canning and Undem, 1994). On the basis of the effects of receptor-selective agonists and antagonists available at the time of those studies, we suggested that these responses of the NANC parasympathetic ganglion neurons were mediated by tachykinins acting on both NK3 and NK1 receptors. Taking advantage of the newly developed NK1 and NK3 receptor-selective antagonists SR 140333 (Edmonds-Alt et al., 1993) and SR 142801 (Emonds-Alt et al., 1995), respectively, we undertook the present study to examine this hypothesis further.

    Materials and Methods
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Functional studies. Guinea pigs were asphyxiated in a vessel filled with 100% CO2 and exsanguinated. The trachea, esophagus and associated nerves were removed in toto and pinned dorsal side down to the bottom of a water-jacketed dissecting dish continuously overfilled (20 ml/min) with warmed (37°C), oxygenated Krebs' buffer of the following composition (mM): NaCl (118), KCl (5.4), Mg2SO4 (1.2), NaH2PO4 (1), CaCl2 (1.9), NaHCO3 (25) and dextrose (11.1). The trachea, esophagus and associated nerves were dissected free from extraneous tissues and prepared for measurement of isometric tension of the trachealis as previously described (Canning and Undem, 1993a). Two adjacent cartilage rings (rings 6 and 7 caudal to the larynx) were cut open opposite the trachealis. One end of the opened rings was sutured to a pin in the bottom of the dissecting dish, and the other end was sutured to a force transducer (Grass FT03; Grass Instruments, Cambridge, MA) connected to a Grass polygraph (Model 7D) for measurement of isometric tension. Optimal base-line tone (1.5 g) was set and was continually adjusted during the ensuing 90-min equilibration period.

Vagal nerve fibers project to the guinea pig trachea in two major branches of the primary nerve: the recurrent laryngeal nerves, which branch off the vagi near the mainstem bronchi, and the superior laryngeal nerves, which originate near the inferior vagal sensory ganglia (the nodose ganglia) adjacent to the larynx. The preganglionic parasympathetic fibers and the capsaicin-sensitive vagal afferent fibers that innervate the rostral portions of the trachea and esophagus are carried by the recurrent and superior laryngeal nerves, respectively (Canning and Undem, 1993a). These distinct vagal pathways were stimulated as previously described (Canning and Undem, 1993a, 1993b, 1994). The vagus nerves were cut caudal to the nodose ganglia, and suction electrodes were placed on the cut ends of the vagus nerves rostral (stimulating only those fibers that project axons to the superior laryngeal nerves) and caudal (stimulating only those fibers that project axons to the recurrent laryngeal nerves) to the nodose ganglia. The suction electrodes were connected to a Grass stimulator (Model S44) that delivered square pulses of optimum stimulus intensities (150 V, pulse duration 1 msec). The nerves were stimulated bilaterally for 10 sec at frequencies between 4 and 24 Hz.

Relaxations were elicited after addition of atropine and contraction of the trachealis with 5 µM histamine. The magnitude of the vagally mediated relaxations were expressed as a percentage of the maximum relaxant response elicited by 0.1 mM papaverine administered at the end of each experiment.

The effects of SR 142801, SR 140333 and CP 99994 on vagally mediated relaxations of the trachealis were assessed in nonpaired experiments (this was necessary because of the long equilibration period required for SR 142801; see Emonds-Alt et al., 1995). Preparations were pretreated with vehicle, SR 142801 or both SR 142801 and either SR 140333 or CP 99994 (0.3 µM each) at the outset of each experiment, and the relaxations elicited in tissues treated with vehicle were compared with those elicited in tissues treated with the antagonists.

The effects of SR 142801 on capsaicin-induced, esophagus-dependent relaxations of the trachealis were also assessed. Tissues were prepared as described above (after removal of the extrinsic nerves; see Canning and Undem, 1994) and suspended in water-jacketed organ baths filled with warmed (37°C), oxygenated Krebs' buffer. One end of the preparation was sutured to the bottom of the organ bath, and the other end was sutured to an isometric force transducer connected to a Grass polygraph. Base-line tone was set at 1.5 g, and the buffer bathing the tissues was changed at 15-min intervals during the 90-min equilibration. After equilibration, the tissues were contracted with 5 µM histamine. When the contraction to histamine had stabilized, the NK3-selective agonist senktide analog (0.3 µM) was added to assess the integrity of the neural projections from the esophagus to the trachea (senktide analog elicits relaxations of the trachealis only when the adjacent esophagus, and consequently the NANC relaxant nerve pathways to the trachealis, are intact; Canning and Undem, 1994). Preparations that did not relax to senktide analog (<5%) were not studied further.

When the response to senktide analog reached maximum, the tissues were washed repeatedly for 45 min and then treated with vehicle (DMSO), TTX (1 µM) or 0.3 µM SR 142801 for 2 hr. At the end of the drug equilibration period, the trachealis was recontracted with 5 µM histamine, and cumulative concentration-response curves to capsaicin (0.01 µM-10 µM) were constructed. Each successive dose of capsaicin was added when the response to the previous dose had peaked. The magnitude of these relaxant responses was expressed as a percentage of the contraction elicited by histamine.

The effects of tachykinin receptor antagonists on senktide analog- and substance P-induced relaxations of the trachealis were also assessed. Experiments were carried out as described above, except that rather than adding capsaicin after antagonist administration and recontraction of the trachealis with histamine, we added 0.3 µM senktide analog or 1 µM substance P. The responses elicited were expressed as a percentage of the relaxant response elicited by senktide analog at the outset of the experiment.

Previous studies indicated that NK2 receptors are not involved in the relaxations elicited by stimulation of the capsaicin-sensitive nerves or by exogenously administered tachykinins (Canning and Undem, 1994). Accordingly, to eliminate any possible functional antagonism mediated by activation of the NK2 receptors on the smooth muscle (Ellis and Undem, 1994), unless otherwise stated we carried out all of our functional experiments in the presence of the NK2 receptor antagonist SR 48968 (0.1 µM).

To test for selectivity of the receptor antagonists, we assessed their effects on contractions elicited by capsaicin (predominantly an NK2 receptor-mediated response; Ellis and Undem, 1994), the NK2-selective agonist beta Ala8NKA4-10 and/or the NK1-selective agonist ASMSP. Antagonists were added at least 2 hr before construction of the concentration-response curves. If significant shifts in the curves were generated, a pKb for the antagonists was calculated as previously described (Renzetti et al., 1992).

To test for effects of the antagonists on NANC relaxations independent of tachykinin receptor antagonism (i.e., pre- or postjunctional effects), EFS-induced NANC relaxations were elicited in the absence and presence of the antagonists. Tracheal strips were suspended in an organ bath as described above. After a 2-hr pretreatment with the tachykinin receptor antagonists or vehicle, the trachealis was contracted with 5 µM histamine. When the contraction to histamine had stabilized, EFS was delivered through bipolar platinum ring electrodes placed on either side of the tracheal strips. The electrodes were connected to a Grass stimulator (Model S44) connected in series to a Med-Lab Stimusplitter (Med-Lab Instruments, Fort Collins, CO) that amplified and measured the stimulus intensity. Tissues were stimulated with optimum stimulus intensities (12 V, 1 msec, 200-400 mA) at frequencies of 0.1 to 32 Hz. Frequency-response curves were constructed in a cumulative manner, the frequency being increased when the response to the ongoing stimulus had stabilized. The magnitude of relaxations elicited by EFS were expressed as a percentage of the maximum relaxation elicited by 0.1 mM papaverine (added at the end of each experiment).

Pretreatments. Unless otherwise stated, atropine (1 µM), propranolol (1 µM) and indomethacin (3 µM) were added to the buffer to limit the influence of cholinergic and adrenergic nerves and the effects of neuromodulatory prostanoids, respectively (Canning and Undem, 1993a, 1994). Also, unless otherwise stated, 0.1 µM SR 48968 was added to block tachykinin-mediated contractions of the trachealis via NK2 receptor activation.

Immunohistochemistry. Tissue preparation for the immunohistochemical analyses was carried out as previously described (Kummer et al., 1992). Guinea pigs were sacrificed by inhalation of CO2 and exsanguinated. The esophagus (the location of the cell bodies of the neurons that mediate NANC relaxations of the trachealis; Canning and Undem, 1993b; Canning et al., 1996) was removed in toto, fixed overnight in 4% paraformaldehyde in 0.1% phosphate buffer, washed in 0.1% PBS and stored until freezing in 0.1% phosphate buffer containing 18% sucrose for cryoprotection. The esophagus was then frozen rostral end up in quickmount on filter paper, and serial transverse sections (12 µm) were made on a cryostat and placed on chromalum-coated slides.

Immunohistochemical localization of VIP-, NOS- and substance P-IR nerve fibers and nerve cell bodies was carried out as previously described (Kummer et al., 1992; Fischer et al., 1993). Sections were incubated for 1 hr in blocking solution consisting of 1% bovine serum albumin, 10% normal swine serum and Tween 20 (to enhance tissue penetration of the antisera) in PBS. After several washes in PBS, the slides were coated with buffer containing monoclonal mouse antibodies to substance P (1:800; kindly provided by Dr. J.-Y. Couraud, Gif-sur-Yvette, France) and polyclonal rabbit antibodies to either the neuronal isoform of NO synthase (1:1000; kindly provided by B. Mayer, Graz, Austria) or VIP (1:1000; Immuno Nuclear, Stillwater, MN) for 16 hr. The tissues were then washed twice and incubated for 1 hr with the secondary antisera to the anti-substance P (biotinylated sheep anti-mouse; Amersham, Buchler, Braunschweig FRG) followed by a 1-hr incubation in the secondary antisera to VIP and NOS (FITC-labeled goat anti-rabbit; Organon Teknika, Eppelheim, FRG) and strepavidin Texas Red (Amersham). The slides were then washed and coverslipped in carbonate-buffered glycerol (pH 8.6). FITC- and Texas Red-labeled nerve fibers and nerve cell bodies were visualized and photographed as previously described (Kummer et al., 1992).

Presentation of data and statistical analysis. Results are presented as a mean ± (S.E.M.) for n experiments, where n is the number of animals studied. Relaxations elicited by capsaicin are expressed as a percentage of the contraction elicited by histamine. Contractions elicited by capsaicin under conditions that normally favor relaxations (trachea isolated with the adjacent esophagus intact, precontracted with histamine) were recorded as no response or 0% of the histamine-induced contraction. Relaxations elicited by vagus nerve stimulation or EFS are expressed as a percentage of the maximum relaxation elicited by 0.1 mM papaverine. Relaxations elicited by senktide analog or substance P are expressed as a percentage of the pretreatment (control) response to senktide analog. Contractions elicited by beta Ala8NKA4-10 and ASMSP are expressed as a percentage of the maximum contraction elicited by the agonists. EC50 values for ASMSP and beta Ala8NKA4-10 were determined by visual inspection of the dose-response curves. For the antagonists studies, pKb values were calculated as previously described (Renzetti et al., 1992).

Statistical comparisons of group means were carried out using analysis of variance (ANOVA). When statistically significant differences among group means were detected, individual group means were compared using Scheffé's F test for unplanned comparisons. A P value < .05 was considered significant.

Drugs. Atropine sulfate, capsaicin, indomethacin, DL-propranolol, papaverine hydrochloride, histamine diphosphate and (TTX) were bought from Sigma (St. Louis, MO). CP 99994 was a generous gift from Merck Frosst (Quebec, Canada). SR 142801 and SR 142806 were gifts from SmithKline Beecham (King of Prussia, PA). Substance P, beta Ala8NKA4-10, ASMSP, senktide analog, SR 140333 and SR 48968 were gifts from Zeneca, Inc. (Wilmington, DE). Atropine (10 mM), propranolol (10 mM), papaverine (50 mM), substance P (1 mM), senktide analog (1 mM), TTX (1 mM) and histamine (20 mM) were dissolved in water. ASMSP (1 mM), beta Ala8NKA4-10 (1 mM), CP 99994 (1 mM), SR 142801 (1 mM), SR 142806 (1 mM) and SR 48968 (10 mM) were dissolved in DMSO. Indomethacin (30 mM) and capsaicin were dissolved in ethanol.

    Results
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Immunohistochemistry. Neuronal cell bodies possessing immunoreactivity to VIP and NOS were found throughout the myenteric plexus of the guinea pig esophagus (fig. 1). This plexus is located between the outer longitudinal and inner circular striated muscle layers of the esophagus and is the probable location of the neurons that mediate NANC relaxations of the trachealis (Canning and Undem, 1993b; Canning et al., 1996). Double-labeling studies revealed that neurons within the myenteric plexus expressing VIP and NOS-IR were enveloped by substance P-containing nerve fibers (fig. 1). Substance P-immunoreactivity was not seen in any perikarya within the esophageal myenteric plexus.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 1.   Double-labeling immunohistochemical demonstration of VIP- and NO synthase-IR nerve cell bodies (identified with arrows) in the myenteric plexus of the guinea pig esophagus (the probable location of the perikarya of the parasympathetic ganglion neurons that mediate NANC relaxations of the adjacent trachea; see Canning and Undem, 1993b and Canning et al., 1996) and their innervation by substance P-IR nerve fibers. The substance P-IR nerve fibers illustrated in panels C and D are localized by double-labeling immunohistochemistry to the ganglia that contain VIP- and NOS-IR neurons, depicted in panels A and B, respectively. Micrographs are representative of five similar experiments. Calibration bar = 30 µm.

Effect of tachykinin receptor antagonists on vagally mediated relaxations. Stimulation (24 Hz, 10 sec) of the rostral (capsaicin-sensitive) and caudal (parasympathetic) vagal pathways that innervate the guinea pig trachea elicited relaxations of the precontracted (5 µM histamine) trachealis that averaged 18 ± 8% and 35 ± 4%, respectively, of the maximum relaxation elicited by 0.1 mM papaverine (n = 8). The NK3-selective antagonist SR 142801 (0.3 µM) markedly inhibited relaxations of the guinea pig trachea elicited by stimulation of the capsaicin-sensitive vagal pathways. Addition of both SR 142801 and either of the NK1-selective antagonists SR 140333 (0.3 µM) and CP 99994 (0.3 µM) virtually abolished relaxations elicited by stimulation of the rostral (capsaicin-sensitive) vagal pathways (fig. 2A). The combination of SR 140333 and SR 142801 also abolished capsaicin-induced (0.1-10 µM) relaxations in this preparation (n = 4).


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of tachykinin receptor antagonists on NANC relaxations of the guinea pig trachea elicited by stimulation (24 Hz, 10 sec) of the capsaicin-sensitive vagal relaxant pathways (see Canning and Undem, 1993a, 1994 for details) (panel A) or by electrical field stimulation (panel B). A) Mean data for relaxations elicited by stimulating the rostral (capsaicin-sensitive) vagal pathways in the presence of vehicle (n = 8), SR 142801 (n = 8), both SR 140333 and SR 142801 (n = 4) or both SR 142801 and CP 99994 (n = 4). B) Lack of inhibitory effect of the tachykinin receptor antagonists on EFS-induced NANC relaxations of the guinea pig trachealis (n = 8). Frequency-response curves were generated cumulatively. Relaxant responses elicited by nerve stimulation are expressed as a percentage of the maximum relaxant response elicited by 0.1 mM papaverine. Data are presented graphically as the mean ± s.e.m.

NANC relaxations elicited by stimulation (24 Hz, 10 sec) of the preganglionic parasympathetic nerves (the caudal vagal pathways; see "Materials and Methods") were not affected by SR 142801, averaging 35 ± 4% and 34 ± 11% of the maximum relaxant response in the presence of vehicle (n = 8) and in the presence of 0.3 µM SR 142801 (n = 8), respectively (P > .05). The combination of SR 142801 and the NK1 antagonists was also without marked effect on relaxations elicited by parasympathetic nerve stimulation, averaging 47 ± 9% and 18 ± 10% of the maximum relaxant response in the presence of SR 142801 and either CP 99994 (n = 4) or SR 140333 (n = 4), respectively. NANC relaxations elicited by EFS were also not inhibited by the tachykinin receptor antagonists (fig. 2B).

Effect of tachykinin receptor antagonists on capsaicin-induced relaxations. In results consistent with our previous studies (Canning and Undem, 1994), capsaicin elicited concentration-dependent relaxations of the guinea pig trachea isolated with the adjacent esophagus intact that were abolished by 1 µM TTX but were unaffected by NK2 receptor antagonism with 0.1 µM SR 48968 (fig. 3A). The NK3-selective receptor antagonist SR 142801 (0.3 µM) markedly inhibited capsaicin-induced relaxations of the trachealis (fig. 3B). Indeed, 4 of 11 preparations failed to relax to capsaicin in the presence of SR 142801 (and SR 48968). The less active isomer of SR 142801, SR 142806 (0.3 µM), was ineffective at inhibiting capsaicin-induced relaxations of the trachealis (fig. 3C).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   Capsaicin-induced relaxations of the guinea pig trachealis. Tracheae were isolated with the adjacent esophagus intact and suspended in organ baths as described in "Materials and Methods." All tissues were pretreated with the NK2 receptor antagonist SR 48968 (0.1 µM). Relaxations are expressed as a percentage of the precontraction of the trachealis elicited by 5 µM histamine. In both the presence and the absence of 0.1 µM SR 48968, capsaicin failed to elicit relaxations of the trachealis when the trachea was separated from the adjacent esophagus (n = 3). Relaxations were elicited in the absence (square , n = 8) and in the presence (black-square) of 1 µM tetrodotoxin (n = 5; panel A), the NK3 receptor antagonist SR 142801 (0.3 µM, n = 10; panel B) and the less active isomer of SR 142801, SR 142806 (0.3 µM, n = 3; panel C). An asterisk (*) denotes a statistically significant decrease in the magnitude of capsaicin-induced relaxations compared with vehicle control (P < .05).

Effects of tachykinin receptor antagonists on tachykinin-mediated responses. Substance P (1 µM) elicited esophagus-dependent, TTX-sensitive relaxations of the precontracted guinea pig trachea (fig. 4). The NK1-selective receptor antagonists CP 99994 and SR 140333 and the NK3-selective receptor antagonist SR 142801 (each at 0.3 µM) inhibited relaxations of the trachealis elicited by substance P. Addition of both SR 140333 and SR 142801 abolished substance P-induced relaxations (fig. 4).


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 4.   Effect of tachykinin receptor antagonists on 1 µM substance P-induced relaxations of the isolated guinea pig trachea. Guinea pig tracheae were isolated with the adjacent esophagus intact as described in "Materials and Methods." All experiments with substance P were carried out in tissues pretreated with 0.1 µM SR 48968. Substance P failed to relax the trachealis in preparations that had been separated from the adjacent esophagus (n = 3), and as previously reported (Canning and Undem, 1994), substance P-induced relaxations are abolished by TTX. Relaxations elicited by substance P in the presence of vehicle (DMSO; n = 9), either of the NK1 receptor antagonists CP 99994 (n = 6) and SR 140333 (n = 5), the NK3 receptor antagonist SR 142801 (n = 8) or both SR 140333 and SR 142801 (n = 3) are presented as a mean ± s.e.m. percentage of the reference relaxant response elicited by the NK3 receptor-selective agonist senktide analog (0.3 µM) at the outset of each experiment (see "Materials and Methods" for details of the experimental design). An asterisk (*) denotes a statistically significant decrease in the magnitude of substance P-induced relaxations compared with vehicle control (P < .05).

In parallel experiments, we assessed the specificity of the antagonists used in this study against agonists selective for NK1 (ASMSP) and NK2 (beta Ala8NKA4-10) receptors and by examining their effects on capsaicin-induced contractions of the trachealis (a predominantly NK2 receptor-mediated response; Ellis and Undem, 1994). SR 142801 (0.3 µM) was without effect on beta Ala8NKA4-10- and ASMSP-mediated contractions of the guinea pig trachea [pA2 < 6.5 at both NK2 (n = 2) and NK1 receptors (n = 3)] and was without effect on contractions of the guinea pig trachea elicited by capsaicin (1 µM capsaicin elicited contractions of the guinea pig trachea that averaged 71 ± 6% and 62 ± 6% in the absence and presence of 0.3 µM SR 142801, respectively; n = 4, P > .1). By contrast, SR 140333 and CP 99994 (each studied at 0.3 µM) caused marked leftward shifts in the concentration-response curve for ASMSP (estimated pKb values of 8.8 ± 0.4 and 9.1 ± 0.1, respectively; n = 3) but were without marked effect on capsaicin-induced contractions of the trachealis (1 µM capsaicin elicited contractions that averaged 72 ± 5%, 71 ± 4% and 45 ± 8% in the presence of vehicle, 0.3 µM SR 140333 and 0.3 µM CP 99994, respectively; n = 3).

The effects of the tachykinin receptor antagonists on relaxations of the guinea pig trachea elicited by the NK3-selective agonist senktide analog are illustrated in figure 5. Senktide analog (0.3 µM) elicited esophagus-dependent, TTX-sensitive relaxations of the trachealis that were virtually abolished by 0.3 µM SR 142801 but were not affected by 0.3 µM SR 142806, SR 140333 or 0.3 µM CP 99994. In results consistent with previous studies (Canning and Undem, 1994), senktide analog-induced relaxations were also unaffected by a selective concentration of the NK2 receptor antagonist SR 48968. Senktide analog elicited relaxations that averaged 38 ± 4% and 36 ± 3% of 5 µM histamine-induced contractions in the absence (n = 31) and presence (n = 61) of 0.1 µM SR 48968, respectively (P > .1).


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 5.   Effect of tachykinin receptor antagonists and TTX on relaxations of the isolated guinea pig trachea elicited by the NK3 receptor-selective agonist senktide analog (0.3 µM). Guinea pig tracheae were isolated with the adjacent esophagus intact as described in "Materials and Methods." Senktide analog failed to relax the trachealis in preparations that had been isolated without the adjacent esophagus intact (n = 3). Relaxations elicited by senktide analog after the addition of vehicle (n = 8), the tachykinin receptor antagonists (n = 6-7) or TTX (n = 3) are expressed as a percentage of the control relaxant response elicited by senktide analog before drug administration (see "Methods" for details of the experimental design) and are presented graphically as the mean ± s.e.m. Pretreatment with the less active isomer of SR 142801, SR 142806 (0.3 µM), was without effect on senktide analog-induced relaxations (89 ± 51% of control response, n = 4; p > .1). An asterisk (*) denotes a statistically significant decrease in the magnitude of senktide analog-induced relaxations compared with vehicle control (P < .05).

    Discussion
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

In the present study, we provide anatomical and pharmacological evidence for tachykinin-mediated activation of neurons that mediate NANC relaxations of guinea pig trachealis. More specifically, we demonstrate the presence of a dense network of tachykinin-containing nerve fibers innervating the neurons that are thought to mediate these relaxations and show that either electrical or chemical stimulation of these nerve endings elicits relaxations of the guinea pig trachealis that are inhibited by tachykinin receptor antagonists. Finally, using antagonists selective for each of the identified tachykinin receptor subtypes, we present evidence that relaxations of the guinea pig trachealis elicited by peripheral activation of the capsaicin-sensitive vagal afferent nerves involve activation of both NK1 and NK3 receptors.

Interactions between capsaicin-sensitive afferents and NANC relaxant nerves. NANC relaxations of the guinea pig trachea are thought to be mediated by VIP and/or NO coreleased from postganglionic parasympathetic nerves (Tucker et al., 1990; Li and Rand, 1991; Canning and Undem, 1993a, Canning et al., 1996). Using an isolated, innervated guinea pig tracheal preparation, we had previously described two vagal pathways that mediate NANC relaxations of the guinea pig trachea: a parasympathetic pathway with preganglionic fibers carried by the recurrent laryngeal nerves and a capsaicin-sensitive pathway made up of afferent fibers carried by the superior laryngeal nerves (Canning and Undem, 1993a). Surprisingly, both of the vagal pathways that mediate relaxations of the guinea pig trachea were disrupted when the trachea was separated from the adjacent esophagus. On the basis of the results of experiments in which ganglionic blockers were administered selectively to the trachea and subsequent experiments with organotypic cultures, pharmacological analyses and immunohistochemistry, we concluded that NANC relaxations of the guinea pig trachea are mediated by nerve fibers emanating from parasympathetic ganglia that are intrinsic to the adjacent esophagus (Canning and Undem, 1993b; Canning et al., 1996).

The observation that antidromic stimulation of capsaicin-sensitive vagal afferent fibers elicited relaxations of the guinea pig trachea seemed incompatible with what was known of the efferent function of these nerves in the airways. Stimulation of capsaicin-sensitive sensory nerves elicits tachykinin-mediated contractions of airway smooth muscle via activation of NK1 and NK2 receptors on the smooth muscle (Renzetti et al., 1992; Ellis and Undem, 1994). On the basis of our studies of the parasympathetic pathways that mediate relaxations of the guinea pig trachea, we reasoned that the capsaicin-sensitive nerve fibers may act to elicit relaxations through intermediate neurons (e.g., parasympathetic ganglion neurons) that are intrinsic to the esophagus. Subsequent studies demonstrating that both capsaicin and exogenously administered tachykinins can elicit relaxations of the trachealis that are TTX-sensitive and esophagus-dependent provided compelling support for this hypothesis (Canning and Undem, 1994).

In the present study, we have demonstrated that the cell bodies of neurons with VIP-IR and/or NOS-IR phenotypes in the myenteric plexus of the esophagus are enveloped by substance P-containing nerve fibers. Indeed, a striking observation is the density of substance P-IR nerve fibers innervating all the neurons of the myenteric plexus of the esophagus (B. J. Canning, A. Fischer and B. J. Undem, unpublished observations). This suggests an important role for tachykinins in regulating neurons localized to the esophagus and provides an anatomical basis for an interaction between neurons that mediate NANC relaxations of the trachealis and capsaicin-sensitive visceral afferent fibers that innervate the ganglia in which they are contained.

Role of tachykinins in mediating relaxations of guinea pig tracheal smooth muscle. Previous studies indicated that relaxations of the guinea pig trachea elicited by capsaicin or antidromic stimulation of the capsaicin-sensitive vagal afferent nerves are mediated by tachykinins (Canning and Undem, 1994). At the time of our previous study, however, potent and selective NK3 receptor antagonists to carry out the necessary pharmacological analyses were not available. Nevertheless, on the basis of the effects of NK3-selective agonists and the inhibitory effects of a nonselective NK3 receptor antagonist (SR 48968), we proposed that the relaxations elicited by stimulation of the capsaicin-sensitive nerves were mediated at least in part by NK3 receptors.

The results of the present study provide compelling evidence that NANC relaxations of the guinea pig trachea mediated by the capsaicin-sensitive vagal afferent fibers involve activation of NK3 receptors. Thus the potent and NK3 receptor-selective antagonist SR 142801 markedly inhibited relaxations elicited by chemical (capsaicin) or electrical stimulation of the capsaicin-sensitive vagal relaxant pathway or by substance P.

We had also published compelling evidence for the involvement of NK1 receptors in the relaxant responses of the trachealis that are mediated by the capsaicin-sensitive vagal pathways (Canning and Undem, 1994). The involvement of NK1 receptors in this response is further supported by the observation in the present study that the NK1 receptor-selective antagonists SR 140333 and CP 99994 inhibited both vagally mediated and substance P-induced relaxations of the trachealis.

The present study also provides further evidence for NK2 receptor-independent mechanisms of relaxations of the guinea pig trachealis elicited by stimulation of capsaicin-sensitive vagal afferent nerves: capsaicin, substance P and senktide analog elicit TTX-sensitive relaxations of the trachealis in the presence of the NK2-selective antagonist SR 48968.

Having found that adding either CP 99994 or a concentration of SR 48968 that blocks NK3 receptors (in addition to NK2 receptors) could in many instances abolish relaxations elicited by stimulation of the capsaicin-sensitive nerves, we speculated that relaxations mediated by the endogenously released tachykinins might require activation of both receptor subtypes on the noncholinergic parasympathetic ganglion neurons (Canning and Undem, 1994). The results of the present study are, however, inconsistent with the hypothesis that the relaxations are mediated by such a synergistic interaction between NK1 and NK3 receptors. Blocking NK2 receptors leaves the NK3 receptor antagonist SR 142801, when administered alone, unable to abolish completely the relaxations elicited by stimulation of the capsaicin-sensitive nerves or by substance P. This may explain in part the observation that the effects of only NK1 or only NK3 receptor blockade were not consistent, causing inhibition that varied from no effect whatsoever to complete abolishment of the responses to capsaicin, substance P or nerve stimulation. It seems likely that factors such as the local concentrations of the tachykinins (each with its own relative potency at NK1 and NK3 receptors), their access to both receptor subtypes and the relative level of expression of these subtypes within the ganglia of any given preparation all contribute to the observed variability and the relative inhibitory effects of the antagonists. In any event, it is clear that tachykinins can elicit activation of the parasympathetic ganglion neurons by activating either NK1 or NK3 receptors.

Contribution of other cells and other mechanisms to capsaicin-mediated relaxations. Although the results of the present study argue strongly for the involvement of tachykinin receptors on the NANC inhibitory neurons in the relaxations elicited by stimulation of the capsaicin-sensitive nerves, the possibility that other cells and mechanisms are involved cannot be discounted. Thus stimulation of the capsaicin-sensitive nerves may induce relaxations by activating, via tachykinins or other transmitters found in the capsaicin-sensitive nerve endings, non-neural cells associated with the airways that might subsequently release a substance that relaxes the guinea pig trachealis (Figini et al., 1996). Alternatively, capsaicin may also act directly on the smooth muscle (Ellis et al., 1996) or induce the release of a relaxant neurotransmitter that acts directly on the smooth muscle (Bhogal et al., 1994; Pinto et al., 1996).

Physiological implications. The interaction described here between tachykinin-containing visceral afferent nerves and the nerves that mediate NANC relaxations of the guinea pig trachealis is one of several reported instances where autonomic nerve function is regulated peripherally by visceral afferent fibers. Similar interactions have been reported in parasympathetic ganglia that innervate the bladder and gallbladder (Mawe, 1995; de Groat and Booth, 1993) and in the parasympathetic, sympathetic and myenteric ganglia that innervate the GI tract (Kreulen and Peters, 1986; Szurzewski and King, 1989). In the airways, both direct (Myers and Undem, 1993; Myers et al., 1996) and indirect evidence for such interactions has been reported for the nerves that regulate airway smooth muscle tone (Martling et al., 1984; Myers and Undem, 1991; Watson et al., 1993; Canning and Undem, 1994). Interestingly, in the ferret trachea, substance P-containing nerve fibers preferentially innervate ganglia that contain VIP-IR and NOS-IR neurons, whereas the cholinergic neurons found in the longitudinal nerve trunks of the ferret trachea are sparsely innervated by substance P-containing nerve fibers (Dey et al., 1996). In the human airway, VIP-IR and NOS-IR neurons are also innervated by substance P-containing nerves (Fischer and Hoffman, 1996). The prevalence of these interactions in autonomic ganglia suggests that peripheral reflexes may be an important aspect of autonomic regulation.

The esophageal location of the interaction between the airway relaxant nerves and capsaicin-sensitive afferent nerves is also of interest. Given the location, it seems possible that stimulation of afferent fibers that innervate the esophagus might elicit effects on airway smooth muscle tone. Such an association of the esophageal innervation with the human airways (or the airways of any other species) has not been assessed, but this suggests a novel mechanism for the respiratory symptoms of gastroesophageal reflux disease (Mansfield and Stein, 1978; Mansfield et al., 1981). Finally, given the recent focus on tachykinin receptor antagonists as potential therapeutic agents (Canning, 1997), the data presented in this study provide further evidence that NK3 receptor antagonists might be useful in the treatment of disorders that involve alterations in autonomic nerve activity.

    Acknowledgments

The authors thank Ms. Sandra Reynolds and Mr. Martin Bodenbenner for expert technical assistance.

    Footnotes

Accepted for publication September 19, 1997.

Received for publication February 27, 1997.

1 This research was made possible by grants and a cooperative agreement between the National Institutes of Health (Bethesda, MD) and the German Health Ministry (Bonn, Germany).

Send reprint requests to: Brendan J. Canning, Ph.D., The Johns Hopkins Asthma and Allergy Center, 5501 Hopkins Bayview Circle, Baltimore, MD 21224.

    Abbreviations

NKA, neurokinin A; NKB, neurokinin B; NK1 (2 or 3), neurokinin1 (2 or 3); EFS, electrical field stimulation; NANC, nonadrenergic, noncholinergic; VIP, vasoactive intestinal polypeptide; NOS, nitric oxide synthase; IR, immunoreactive; TTX, tetrodotoxin; PBS, phosphate-buffered saline; CP 99994, (+), (2S, 3S)-3-(2-methoxybenzyl-amino)-2-phenyl-piperidine); SR 142801, (S)-(N)-(1-(3-(1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl)propyl)-4-phenylpiperidin-4-yl)-N-methylacetamide) ; SR 142806, (R)-(N)-(1-(3-(1-benzoyl-3-(3,4-dichlorophenyl) piperidin-3-yl)propyl)-4-phenylpiperidin-4-yl)-N-methylacetamide ; ASMSP, Ac-[Arg6, Sar9, Met (O2)11]-SP6-11; senktide analog, [Asp6, Asp7, MePhe8]-SP6-11); SR 140333, (S)1-[2-[3-(3,4-dichlorophenyl)-1-(3-isoproproxy phenylacetyl)piperidin-3-yl]ethyl]-4-phenyl-1-azoniabicyclo[2.2.2.]octane chloride; SR 48968 (S)-N-methyl-N[4-(4-acetylamino-4-phenyl piperidino)-2-(3, 4-dichlorophenyl)butyl]benzamide; DMSO, dimethyl sulfoxide; FITC, Fluorescein-isothiocyanate.

    References
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References


0022-3565/98/2841-0370$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
Y. M. Kang, K. Lamb, G. F. Gebhart, and K. Bielefeldt
Experimentally induced ulcers and gastric sensory-motor function in rats
Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G284 - G291.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts
Nitric Oxide in Health and Disease of the Respiratory System
Physiol Rev, July 1, 2004; 84(3): 731 - 765.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
S. Daoui, B. D'Agostino, L. Gallelli, X. Emonds Alt, F. Rossi, and C. Advenier
Tachykinins and airway microvascular leakage induced by HCl intra-oesophageal instillation
Eur. Respir. J., August 1, 2002; 20(2): 268 - 273.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
B. J. Canning, S. M. Reynolds, L. U. Anukwu, R. Kajekar, and A. C. Myers
Endogenous neurokinins facilitate synaptic transmission in guinea pig airway parasympathetic ganglia
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2002; 283(2): R320 - R330.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
K. E. Pedersen, C. K. Buckner, S. N. Meeker, and B. J. Undem
Pharmacological Examination of the Neurokinin-1 Receptor Mediating Relaxation of Human Intralobar Pulmonary Artery
J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 319 - 325.
[Abstract] [Full Text]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Canning, B. J.
Right arrow Articles by Undem, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Canning, B. J.
Right arrow Articles by Undem, B. J.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology